Berelowitz Michael 4
4 · Recro Pharma, Inc. · Filed May 14, 2018
Insider Transaction Report
Form 4
Berelowitz Michael
Director
Transactions
- Exercise/Conversion
Common Stock
2018-05-12+13,274→ 19,457 total - Exercise/Conversion
Restricted Stock Units
2018-05-12−13,274→ 0 total→ Common Stock (13,274 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis
- [F2]On May 12, 2017, the reporting person was granted 13,274 restricted stock units, vesting on the first anniversary of the grant date.